Double-blind, randomized, placebo-controlled, parallel group, multi-centre phase III clinical study on the efficacy and tolerability of mesalazine granules vs. placebo for the prevention of recurrence of diverticulitis

Registry ID

EUCTR2007-000680-22

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Dr. Falk Pharma GmbH

Start date

2007-08-22

Completion date

2011-11-15

Last update

2026-08-16

Conditions

• Diverticultits
• Diverticulitis

Summary

-To compare the efficacy and tolerability of mesalazine granules (3 g 5-ASA/d) vs. placebo for the prevention of recurrence of diverticulitis

Locations

• , , Germany
• , , Slovakia
• , , Hungary
• , , UK
• , , Latvia
• , , Poland
• , , Netherlands
• , , Lithuania
• , , Czechia
• , , Estonia

Related clinical trials

• Anastomotic Leakage After Colorectal Surgery.
• Diagnosis of Abdominal Pain Using RNA Levels: The NATURAL Study
• Anastomotic Bleeding in Colorectal Anastomosis Relating to the Placement of the Stapler Spike to the Staple Line
• Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis
• Surgical Site Infection Outcomes in Natural Orifice Intracorporeal Anastomosis and Extraction (NICE) Procedure - The NICE Trial
• Comparison of NOM for ACLD Between Medical and Surgical Ward

View on source registry